Showing results (1-10 of 404) with videos related to
Sort By:
Pageof 41
Hepatology (Baltimore, Md.)|March 19, 2024
MASH clinical trials and drugs pipeline: An impending tsunamiMazen NoureddinFrontiers in Endocrinology|December 20, 2021
Current and Potential Therapies Targeting Inflammation in NASHSomaya Albhaisi, Mazen NoureddinClinics in Liver Disease|April 29, 2022
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney DiseaseEmily Truong, Mazen NoureddinCurrent Gastroenterology Reports|December 3, 2013
Hepatitis delta: epidemiology, diagnosis and management 36 years after discoveryMazen Noureddin, Robert GishClinical Therapeutics|February 14, 2021
Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisShannon Kogachi, Mazen NoureddinThe American Journal of Managed Care|November 8, 2024
Management strategies for metabolic dysfunction-associated steatotic liver disease (MASLD)Naim Alkhouri, Mazen NoureddinClinical Liver Disease|July 28, 2022
Improvement in nonalcoholic fatty liver disease through bariatric surgeryEmily Truong, Mazen NoureddinGastroenterology Clinics of North America|October 19, 2010
Pharmacokinetics and pharmacodynamics of peginterferon and ribavirin: implications for clinical efficacy in the treatment of chronic hepatitis CMazen Noureddin, Marc G GhanyCurrent Hepatology Reports|August 6, 2019
Pathogenesis of NASH: The Impact of Multiple PathwaysMazen Noureddin, Arun J SanyalClinics in Liver Disease|April 30, 2015
Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinomaMazen Noureddin, Mary E RinellaPageof 41